American Association for Cancer Research

Skip to Main Content

Table 4

Follow-up of serum calcitonin: basal and after pentagastrin stimulation

Patient no.	Serum Calcitonin (pg/ml)^a
		Basal					Pentagastrin stimulation
		Before surgery	4–10 days after surgery	Follow-up			Pentagastrin stimulation
1	1135	<10	<10 (30 months)	Negative (30 months)
2	121	<10	<10 (34 months)	ND^b
3	959	<10	<10 (30 months)	Negative (30 months)
4	548	257	338 (48 months)	ND
5	59	<10	<10 (42 months)	Peak, 33 pg/ml (4 months)
6	5671	790	1466 (38 months)	ND
7	4927 No surgery	ND	6178 (21 months)	ND
8	5993	1294	1703 (6 months)	ND
9	5035	1122	508 (22 months)	ND
10	695	306	692 (58 months)	ND
11	36073	ND	128600 (28 months)	ND
12	564	237	600 (34 months)	ND
13	343	275 (6 months)	475 (32 months)	ND

Patient no.	Serum Calcitonin (pg/ml)^a
		Basal					Pentagastrin stimulation
		Before surgery	4–10 days after surgery	Follow-up			Pentagastrin stimulation
1	1135	<10	<10 (30 months)	Negative (30 months)
2	121	<10	<10 (34 months)	ND^b
3	959	<10	<10 (30 months)	Negative (30 months)
4	548	257	338 (48 months)	ND
5	59	<10	<10 (42 months)	Peak, 33 pg/ml (4 months)
6	5671	790	1466 (38 months)	ND
7	4927 No surgery	ND	6178 (21 months)	ND
8	5993	1294	1703 (6 months)	ND
9	5035	1122	508 (22 months)	ND
10	695	306	692 (58 months)	ND
11	36073	ND	128600 (28 months)	ND
12	564	237	600 (34 months)	ND
13	343	275 (6 months)	475 (32 months)	ND

^a

Normal, <10 pg/ml.

^b

ND, not done.